Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
Geburtshilfe Und Frauenheilkunde
|
April 1, 1995
[Prognostic differentiation of ovarian carcinomas by immunohistochemical analysis of estrogen receptor expression]
D G Kieback, M F Press, S K McCamant, et al.
Anticancer Research
|
November 1, 1993
Prognostic significance of estrogen receptor expression in ovarian cancer. Immunoreactive Score (IRS) vs. Composition Adjusted Receptor Level (CARL)
D G Kieback, M F Press, E N Atkinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2001
A randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix
M Follen, E N Atkinson, D Schottenfeld, et al.
The New England Journal of Medicine
|
December 11, 1986
13-cis-retinoic acid in the treatment of oral leukoplakia
W K Hong, J Endicott, L M Itri, et al.
Cancer Treatment Reports
|
March 1, 1986
Ethinyl estradiol and medroxyprogesterone acetate in patients with epithelial ovarian carcinoma: a phase II study
R S Freedman, P B Saul, C L Edwards, et al.
American Journal of Clinical Oncology
|
June 1, 1989
Randomized comparison of viral oncolysate plus radiation and radiation alone in uterine cervix carcinoma
R S Freedman, J M Bowen, E N Atkinson, et al.
Cancer Research
|
November 1, 1993
Improved prediction of survival in advanced adenocarcinoma of the ovary by immunocytochemical analysis and the composition adjusted receptor level of the estrogen receptor
D G Kieback, S K McCamant, M F Press, et al.
Cancer
|
November 15, 1996
Sexual adjustment of patients undergoing gracilis myocutaneous flap vaginal reconstruction in conjunction with pelvic exenteration
C R Ratliff, D M Gershenson, M Morris, et al.
Lancet (London, England)
|
April 15, 1995
p53-based blood test for p53PIN3 and risk for sporadic ovarian cancer
I B Runnebaum, X W Tong, R König, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2000
Docetaxel for patients with paclitaxel-resistant Müllerian carcinoma
C F Verschraegen, T Sittisomwong, A P Kudelka, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
Geburtshilfe Und Frauenheilkunde
|
April 1, 1995
[Prognostic differentiation of ovarian carcinomas by immunohistochemical analysis of estrogen receptor expression]
D G Kieback, M F Press, S K McCamant, et al.
Anticancer Research
|
November 1, 1993
Prognostic significance of estrogen receptor expression in ovarian cancer. Immunoreactive Score (IRS) vs. Composition Adjusted Receptor Level (CARL)
D G Kieback, M F Press, E N Atkinson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 14, 2001
A randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix
M Follen, E N Atkinson, D Schottenfeld, et al.
The New England Journal of Medicine
|
December 11, 1986
13-cis-retinoic acid in the treatment of oral leukoplakia
W K Hong, J Endicott, L M Itri, et al.
Cancer Treatment Reports
|
March 1, 1986
Ethinyl estradiol and medroxyprogesterone acetate in patients with epithelial ovarian carcinoma: a phase II study
R S Freedman, P B Saul, C L Edwards, et al.
American Journal of Clinical Oncology
|
June 1, 1989
Randomized comparison of viral oncolysate plus radiation and radiation alone in uterine cervix carcinoma
R S Freedman, J M Bowen, E N Atkinson, et al.
Cancer Research
|
November 1, 1993
Improved prediction of survival in advanced adenocarcinoma of the ovary by immunocytochemical analysis and the composition adjusted receptor level of the estrogen receptor
D G Kieback, S K McCamant, M F Press, et al.
Cancer
|
November 15, 1996
Sexual adjustment of patients undergoing gracilis myocutaneous flap vaginal reconstruction in conjunction with pelvic exenteration
C R Ratliff, D M Gershenson, M Morris, et al.
Lancet (London, England)
|
April 15, 1995
p53-based blood test for p53PIN3 and risk for sporadic ovarian cancer
I B Runnebaum, X W Tong, R König, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2000
Docetaxel for patients with paclitaxel-resistant Müllerian carcinoma
C F Verschraegen, T Sittisomwong, A P Kudelka, et al.
Page
of 8